Gibson Oncology LLC
Gibson Oncology LLC, based in Miami Beach, FL, is at the forefront of brain cancer research, having recently achieved Orphan Drug Designation from the FDA for both Glioblastoma and various types of Gliomas. The company is finalizing discussions with the National Institutes of Health to launch Phase II clinical trials, building on foundational research from multiple prestigious institutions, including Purdue University and Duke University.
With a strong leadership team, including experienced professionals from the fields of medicinal chemistry and neurosurgery, Gibson Oncology is dedicated to advancing innovative treatments for brain tumors. The company has completed several Phase I clinical trials and is poised to release further details as it collaborates with its research partners.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.


